about
Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working GroupConsensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part I. Classification, epidemiology, pathophysiology, genetics, clinical symptoms, and diagnosisClinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.Long-term safety of icatibant treatment of patients with angioedema in real-world clinical practice.Socioeconomic burden of hereditary angioedema: results from the hereditary angioedema burden of illness study in Europe.Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group.HAE international home therapy consensus document.Management of hereditary angioedema in pregnant women: a review.Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment.Development and content validity testing of a patient-reported outcomes questionnaire for the assessment of hereditary angioedema in observational studiesHereditary angioedema: quality of life in Brazilian patients.Social costs of icatibant self-administration vs. health professional-administration in the treatment of hereditary angioedema in Spain.The Icatibant Outcome Survey: treatment of laryngeal angioedema attacks.Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema.Estimation of EuroQol 5-Dimensions health status utility values in hereditary angioedema.Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey.Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part II. Treatment, follow-up, and special situations.Efficacy assessments in randomized controlled studies of acute therapy for hereditary angioedema.Recommendations for the use of in vitro methods to detect specific immunoglobulin E: are they comparable?Treatment Effect and Safety of Icatibant in Pediatric Patients with Hereditary Angioedema.Analysis of characteristics associated with reinjection of icatibant: Results from the icatibant outcome survey.Association between pollen hypersensitivity and edible vegetable allergy: a review.Management of Pregnancy and Delivery in Patients With Hereditary Angioedema Due to C1 Inhibitor Deficiency.Burden of Illness in Hereditary Angioedema: A Conceptual Model.Open-label, multicenter study of self-administered icatibant for attacks of hereditary angioedema.Misdiagnosis trends in patients with hereditary angioedema from the real-world clinical setting.The humanistic burden of hereditary angioedema: results from the Burden of Illness Study in Europe.Ani s 11-Like Protein Is a Pepsin- and Heat-Resistant Major Allergen of Anisakis spp. and a Valuable Tool for Anisakis Allergy Component-Resolved Diagnosis.Psychometric Field Study of Hereditary Angioedema Quality of Life Questionnaire for Adults: HAE-QoL.Clinical Pattern and Acute and Long-term Management of Hereditary Angioedema Due to C1-Esterase Inhibitor Deficiency.Piperacillin-induced DRESS: distinguishing features observed in a clinical and allergy study of 8 patients.Treatment of HAE Attacks in the Icatibant Outcome Survey: An Analysis of Icatibant Self-Administration versus Administration by Health Care Professionals.Chronic urticaria caused by folic acid.Hereditary angioedema with F12 mutation: factors modifying the clinical phenotype.Disease expression in women with hereditary angioedema.Hereditary angioedema caused by the p.Thr309Lys mutation in the F12 gene: a multifactorial disease.[Algorithm for diagnosis and treatment of hereditary angioedema as a tool for management].Current status of implementation of self-administration training in various regions of Europe, Canada and the USA in the management of hereditary angioedema.Occupational asthma caused by artificial cyanoacrylate fingernails.Microarrayed Jug r 1 shows the best diagnostic performance in walnut allergy.
P50
Q27009012-C7D20CB6-FE35-4799-BFD6-14227C6107F0Q27022061-1E438082-BE58-4D0B-930D-9AB638C17352Q33158687-36C484FA-1701-4D04-B371-D990AE4B5D41Q33698175-952D207B-F021-4F87-ACD2-040888DE940EQ33929615-CBB31FB2-586A-4161-B85F-470C2CF6ECE8Q34029593-04648342-B4A9-4D6E-AE07-39F3EEF033BDQ34067727-98858291-D78B-4994-BA46-BD67B246FAA1Q34181274-E27A2392-76F2-4291-8BBF-CD702760CAF0Q34579883-9D9A1F32-B6B9-4421-8947-3A2C0431D56AQ35805244-3E9C71A0-4E3D-45CC-BBD5-6CF2775161CDQ36555078-23E6D9B1-9EC4-4847-AC03-7AD34589EDA4Q36646147-289D1CED-E3D6-4582-9FFB-606429357FDDQ36967735-B373A1EA-6300-47D6-A35D-E07C3A2871BAQ37065138-A72C6280-A344-464D-B2E0-7027E3FA0C7EQ37249076-94D235BB-3FFE-42A2-BA90-379F596F0606Q37690007-E4BD978B-D4A8-4E98-9E89-CA275342A649Q37945256-53CF42D6-E575-4E05-AA2F-0050D066DB0DQ38026489-35D4EB47-7CE5-46B2-BF75-449722A4B78FQ38198050-41D967DD-7CA1-4AF4-ACBC-DDB31191C390Q38375740-4F18840E-D1C0-4190-9B36-413512A4CC95Q38405038-E6A8055A-9892-446E-942B-8CA6C0C2810EQ38552342-F3FFF016-449C-440E-91D2-43DF1CAE6351Q38871882-A3647F57-65BD-4691-83BE-770B0922AF71Q39098342-0876EE96-D313-46F9-91E3-77EA61D77232Q39213357-851C9ABB-5E07-44D7-919B-176504919824Q39290675-59C519B1-AFF7-419A-9909-933807FD02D6Q39309234-B27FF3A4-BCFA-4D2F-B977-D97D874D2BE7Q39859568-5ACD2766-3714-432E-8E46-D8B9F792577AQ39927203-7C66643F-6BAE-439B-B41E-4B8D3560B822Q40148582-1B2310EB-2256-4B70-8BE5-B071C24B5E7AQ40170078-7B3F91D7-7D2A-41A5-BB11-A55315185715Q40796414-22C22D4F-C6C2-40F0-BA58-9E66EA42DAAFQ43296655-4B24FA0A-3CBF-437C-89E2-A0AEB6890956Q44495008-8956762F-A53F-4408-B4FF-D22746A09C52Q44615977-3026BFAA-BDE8-495E-AB15-4FAC9EF6E7BEQ44901102-C4E655CC-106C-4CBE-8AA4-B5327DB16290Q45047929-306414AB-DE21-489F-802F-EECC34FD41AFQ45893080-4006AD08-9171-4DFD-B570-4EBD87CD4E97Q45984666-59E0012B-474F-4A1A-B9C1-02F7D92581CAQ46084303-174C78CC-2D6B-4BCB-A50C-64EA22DF694E
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Teresa Caballero
@ast
Teresa Caballero
@en
Teresa Caballero
@es
Teresa Caballero
@nl
Teresa Caballero
@sl
type
label
Teresa Caballero
@ast
Teresa Caballero
@en
Teresa Caballero
@es
Teresa Caballero
@nl
Teresa Caballero
@sl
prefLabel
Teresa Caballero
@ast
Teresa Caballero
@en
Teresa Caballero
@es
Teresa Caballero
@nl
Teresa Caballero
@sl
P214
P1053
H-6454-2014
P106
P1153
7004564126
P21
P214
P31
P3829
P496
0000-0003-3005-9858